Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Not Exactly What Investors Were Looking For
Motley Fool
Sunday, April 21, 2013 - 10:16am
tags:
EXACT Sciences, Cologuard, colon cancer
Athersys, Inc: The Facts
Seeking Alpha
Sunday, April 21, 2013 - 10:16am
tags:
Athersys
Marking the Way for Alzheimer's Drugs
Motley Fool
Saturday, April 20, 2013 - 11:16am
tags:
Alzheimer's disease, Eli Lilly
Merck & Co Inc (MRK): Today's Featured Health Care Winner
The Street
Saturday, April 20, 2013 - 11:15am
tags:
Merck
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, April 20, 2013 - 11:10am
tags:
Sarepta Therapeutics, EXACT Sciences, Amarin
3 Humongous Health-Care Stocks This Week
Motley Fool
Saturday, April 20, 2013 - 11:09am
tags:
Vertex Pharmaceuticals, Theravance, Alkermes
3 Healthcare Stock Stories For Weekend Investment Wellness
Wall Street Cheat Street
Saturday, April 20, 2013 - 11:04am
tags:
Pluristem Therapeutics, Vertex Pharmaceuticals, Chembio Diagnostics
Is This Stock the Next Big Biotech?
Motley Fool
Saturday, April 20, 2013 - 11:02am
tags:
Vertex Pharmaceuticals
Synthetic Biologics Reiterates that the Infectious Disease Collaboration with Intrexon Remains in Effect
Yahoo/PR Newswire
Saturday, April 20, 2013 - 11:01am
tags:
Synthetic Biologics, Intrexon
Sarepta Therapeutics Inc: Today's Featured Drugs Laggard
The Street
Saturday, April 20, 2013 - 10:58am
tags:
Sarepta Therapeutics
Theravance Inc.: Today's Featured Health Care Laggard
The Street
Saturday, April 20, 2013 - 10:57am
tags:
Theravance
Vertex’s post-test surge holds up as investors clamor to company
MarketWatch
Saturday, April 20, 2013 - 10:55am
tags:
Vertex Pharmaceuticals, VX-661, cystic fibrosis
BMY, Santaris Pharma Team Up
Yahoo/Zacks
Saturday, April 20, 2013 - 10:54am
tags:
Bristol-Myers Squibb, Santaris
Novo Nordisk Unveils New U.S. Headquarters
Yahoo
Friday, April 19, 2013 - 12:25pm
tags:
Novo Nordisk
Russia rejects Abbott Laboratories' plan to buy Petrovax
Reuters
Friday, April 19, 2013 - 12:16pm
tags:
Petrovax, M&A, Abbott Laboratories, Russia
Orphan Drug Biotechs Do It Best
Motley Fool
Friday, April 19, 2013 - 12:14pm
tags:
orphan drugs, Alexion, Biomarin, Vertex Pharmaceuticals
Report: Don't count Celltrion out of Rituxan biosim race
Fierce Biotech
Friday, April 19, 2013 - 12:08pm
tags:
Celltrion, biosimilars, Rituxan
Takeda in more trouble at home over recall of mislabeled vials
Fierce Pharma
Friday, April 19, 2013 - 12:07pm
tags:
Takeda, recalls
Bristol-Myers Squibb: Growing Bigger and Better
Motley Fool
Friday, April 19, 2013 - 12:05pm
tags:
Bristol-Myers Squibb
Vivus Seeing Traction With Qsymia
Seeking Alpha
Friday, April 19, 2013 - 11:53am
tags:
Qsymia, Vivus, Orexigen, Arena Pharmaceuticals, obesity

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.